2025 POLICY ISSUES

1. HTA (Health Technology Assessment)

• HTA is a process that assesses the effectiveness, safety, and cost-effectiveness of health technologies. This approach encompasses medical, economic, social, and ethical aspects. HTA aids in deciding which technologies should be integrated into the healthcare system. AmCham supports the use of HTA to ensure quality, safety, and cost-effectiveness in the healthcare sector.

2. Tobacco and nicotine usage, prevention and control

• Croatia is among the top five European countries in terms of smoking prevalence. Introduction of health policies that cover prevention, smoking cessation programs and creating an environment that defines and positions new nicotine and tobacco products can be beneficial for tobacco and nicotine consumption in Croatia.

3. Green hospitals

• Hospitals are energy-intensive and produce 2.5 times more emissions than commercial buildings. Health systems account for 4.4% of global CO2 emissions, more than aviation or shipping. Hospitals generate 13 kg of waste per bed daily, with 15-25% being hazardous waste. Implementing the concept of green hospitals can bring significant savings in energy, waste, and CO2 emissions, and can also improve treatment outcomes.

4. Private healthcare as a partner of the public system

• The role of private healthcare in the public system is not clearly defined and collaboration is not encouraged while the public sector is under increased pressure. By examining opportunities for collaboration, public-private partnerships in targeted areas of healthcare that have the potential to alleviate the burden on public system should be identified and encouraged.

During 2025, the Committee will monitor legislative changes to be announced and implemented by the Ministry of Health and other responsible institutions and act accordingly. 

Representatives of the following member companies participate in the work of the Committee: 
Abbott Laboratories d.o.o.
AbbVie d.o.o.
Alpheus d.o.o.
Altium International d.o.o.
Amgen d.o.o.
AstraZeneca d.o.o.
Bayer d.o.o.
Becton Dickinson Croatia d.o.o.
CMS Reich-Rohrwig Hainz Rechtsanwälte GmbH - Podružnica Zagreb
Cromedic Assistance d.o.o.
Elemento Content d.o.o.
Eli Lilly (Suisse) S.A. - Predstavništvo u Republici Hrvatskoj
EuroNavigator d.o.o.
Genesis Pharma Adriatic d.o.o.
Grayling d.o.o.
Hrvatski Telekom d.d.
Hrvatsko-američko društvo
International Medical Corps Croatia/Međunarodni Medicinski Zbor Hrvatska
IQVIA Adriatic d.o.o.
Iron Mountain Hrvatska d.o.o.
Johnson & Johnson S.E. d.o.o.
Kiara Maria d.o.o.
Klaster zdravstvenog turizma Kvarnera
Mastercard Europe - Podružnica Zagreb
McKinsey & Company, Inc. Adriatic Podružnica
Medical Intertrade d.o.o.
Medilab One d.o.o.
Medtronic Adriatic d.o.o.
MERCK d.o.o.
Merck Sharp & Dohme d.o.o.
Microsoft Hrvatska d.o.o.
Novartis Hrvatska d.o.o.
Novo Nordisk Hrvatska d.o.o.
Odvjetničko društvo Ilej & Partneri d.o.o.
Odvjetnik Mario Perica
Oktal Pharma d.o.o.
Olympus Czech Group, s.r.o., član koncerna, Podružnica Zagreb
Pfizer Croatia d.o.o.
Philip Morris Zagreb d.o.o.
PHILIPS d.o.o.
Roche d.o.o.
SANDOZ d.o.o.
Saron Management Solutions d.o.o.
Sofmedica Croatia d.o.o.
Solvership d.o.o.
Swixx BioPharma d.o.o.
Takeda Pharmaceuticals Croatia d.o.o
TDR d.o.o.
Udruga digitalnog zdravstva
Visa Europe Management Services Limited, Podružnica Zagreb
Vlahović Grupa d.o.o. - Vlahovic Group Government Relations
Wiener osiguranje Vienna Insurance Group d.d.